IV Ductal Carcinoma In Situ, Including its Histologic Subtypes and Grades
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s12609-021-00439-7.pdf
Reference43 articles.
1. Parikh U, Chhor CM, Mercado CL. Ductal carcinoma in situ: the whole truth. AJR Am J Roentgenol. 2018;210(2):246–55. Epub 2017/10/19. https://doi.org/10.2214/AJR.17.18778. PubMed PMID: 29045181.
2. D’Orsi CJ. Imaging for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):214–7. Epub 2010/10/20. https://doi.org/10.1093/jncimonographs/lgq037. PubMed PMID: 20956833; PMCID: PMC5161079.
3. • Chootipongchaivat S, van Ravesteyn NT, Li X, Huang H, Weedon-Fekjaer H, Ryser MD, Weaver DL, Burnside ES, Heckman-Stoddard BM, de Koning HJ, Lee SJ. Modeling the natural history of ductal carcinoma in situ based on population data. Breast Cancer Res. 2020;22(1):53. Epub 2020/05/29. https://doi.org/10.1186/s13058-020-01287-6. PubMed PMID: 32460821; PMCID: PMC7251719.This paper utilized two well-established population models and evaluated six possbile DCIS natural history submodels. Their results suggest that without biopsy or surgical excision the majority of screen-detected DCIS will progress to invasive breast cancer within relatively short time.
4. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol. 1941;17(4):491–6 3. Epub 1941/07/01. https://doi.org/10.3322/canjclin.32.4.234. PubMed PMID: 19970575; PMCID: PMC1965212.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. Epub 2000/01/27. https://doi.org/10.1016/s0092-8674(00)81683-9. PubMed PMID: 10647931.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Co-delivery of Bcl-2 siRNA and doxorubicin through gold nanoparticle-based delivery system for a combined cancer therapy approach;Journal of Drug Delivery Science and Technology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3